The drug, called tanezumab, inhibits nerve activity and has been found to provide relief in patients with chronic lower back pain - a leading cause of disability. Researchers from the University of Rochester say it is a breakthrough in non-opioid treatment for chronic pain and could provide long-term relief to millions. The drug, called tanezumab, inhibits nerve activity and has been found to provide relief in patients with chronic lower back pain - a leading cause of disability. One of these proteins, called nerve growth factor (NGF), could explain why some people experience more intense pain than others. Lower back pain affects one in ten people worldwide, and causes more disabilities than any other condition.

Source: Daily Mail June 19, 2020 15:59 UTC